Surgical Incision Closures

Global Surgical Incision Closures Market to Reach US$30.4 Billion by 2030

The global market for Surgical Incision Closures estimated at US$21.3 Billion in the year 2024, is expected to reach US$30.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Tissue Sealants, Adhesives & Topical Hemostats, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$14.8 Billion by the end of the analysis period. Growth in the Suture Products segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.6 Billion While China is Forecast to Grow at 9.1% CAGR

The Surgical Incision Closures market in the U.S. is estimated at US$5.6 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.0 Billion by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Surgical Incision Closures Market - Key Trends and Drivers Summarized

The surgical incision closure market is experiencing significant growth, primarily driven by an increase in global surgical procedures due to the rising prevalence of chronic diseases and a growing aging population. Conditions such as diabetes, cardiovascular disease, and cancer often necessitate surgical interventions that require precise and effective wound closure techniques. Additionally, rising patient awareness and expectations for improved post-surgical cosmetic outcomes have accelerated the adoption of advanced closure methods that minimize scarring and reduce recovery time. The demand for less invasive procedures, particularly laparoscopic surgeries that require smaller incisions, has also contributed to the need for innovative closure products that ensure faster wound healing.

A major trend within this market is the shift towards technologically advanced closure solutions. For instance, absorbable sutures, skin adhesives, and antimicrobial sealants are increasingly popular due to their efficiency and ability to reduce the risk of infection. Additionally, advancements in stapling devices and bioabsorbable staplers offer improved outcomes for patients, particularly in complex procedures where traditional sutures might be less effective. The integration of antimicrobial agents within closure materials provides further protection against post-operative infections, a critical factor in patient recovery.

Moreover, the market is seeing a growing interest in wound closure systems that enhance workflow efficiency for healthcare providers. Automated suturing devices and innovative tissue adhesives streamline the closure process, reducing surgery time and improving patient throughput. With the increasing focus on outpatient surgeries and ambulatory care, solutions that minimize post-surgical complications are in high demand. In this context, the continued development of patient-specific and minimally invasive closure techniques will shape future trends, meeting the evolving needs of healthcare providers and patients alike.

SCOPE OF STUDY:

The report analyzes the Surgical Incision Closures market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Segment (Tissue Sealants, Adhesives & Topical Hemostats; Suture Products; Staplers; Other Product Segments)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 51 Featured) -

• 3M Canada
• 3M Company
• Advanced Medical Solutions Group PLC
• B. Braun Medical Ltd.
• Betatech Medical
• Cabrini Health Ltd.
• Cardinal Health, Inc.
• CooperSurgical, Inc.
• CP Medical, Inc.
• DermaClip US LLC

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.